Santangelo Orion, Baldwin Julie Marie, Stogner John
Department of Criminal Justice and Criminology, University of North Carolina at Charlotte, 9201 University City Blvd., Charlotte, NC 28223-0001, United States; Loss Prevention Research Council, 747 SW 2nd Ave, Gainesville, FL 32601, United States.
Department of Justice, Law & Criminology, American University, 4400 Massachusetts Avenue NW, Washington, DC 20016-8043, United States.
Int J Drug Policy. 2022 Aug;106:103756. doi: 10.1016/j.drugpo.2022.103756. Epub 2022 Jun 20.
Though synthetic cannabinoid receptor agonists (SCRAs) were controlled after being introduced as a 'legal high,' SCRAs likely remain appealing to individuals subject to routine drug screens as not all testing programs consistently include SCRAs. Military populations have been linked to SCRAs due to the unconfirmed supposition that testing protocols led many to substitute SCRAs for cannabis. This study aimed to explore SCRA use prevalence, correlates, and use motivations among veterans, with a particular focus on whether United States military personnel substituted SCRAs for cannabis to subvert testing protocols.
All veterans appearing in one of eight civilian criminal courts in three U.S. states were invited to answer questionnaire items related to military service, court functionality, and substance use. Of the 579 veterans eligible, 54.9% chose to participate, yielding a cross-sectional sample of 318 veterans charged with a criminal offense by civilian authorities.
Sixty-five (21.3%) justice-involved veterans reported lifetime SCRA use. Use while within the military was reported by 15.0% of veterans enlisting after 2008. Only eight (12.3%) reported SCRAs were used as a substitute for cannabis. Boredom (36.9%), experimentation (27.7%), and social aspects of SCRA use (32.3%) were more commonly reported motives. Logistic regression models indicated that use of cannabis (aPR=2.06, p<.05), hallucinogens (aPR=2.50, p<.01), and SCRAs (aPR=2.49, p<.05) while in the military were risk factors for SCRA use after leaving the military, whereas older age at time of military exist was a protective factor (aPR=.87, p<.01) CONCLUSIONS: Drug testing programs within the military do not appear to have the unintended consequence of routing individuals to more risky drugs; however, SCRAs appear to have been an underappreciated problem within the military. Further, use extends beyond the military with many only initiating use after discharge, suggesting SCRA use may jeopardize the health of veterans post-service.
尽管合成大麻素受体激动剂(SCRAs)在作为“合法兴奋剂”被引入后受到管控,但SCRAs可能仍然吸引那些接受常规药物筛查的人,因为并非所有检测项目都始终将SCRAs纳入其中。由于未经证实的推测,即检测方案导致许多人用SCRAs替代大麻,军事人员与SCRAs存在关联。本研究旨在探讨退伍军人中SCRAs的使用流行率、相关因素及使用动机,特别关注美国军事人员是否用SCRAs替代大麻以规避检测方案。
邀请在美国三个州的八个民事刑事法庭之一出庭的所有退伍军人回答与军事服役、法庭功能和物质使用相关的问卷项目。在579名符合条件的退伍军人中,54.9%选择参与,产生了一个由318名被民事当局指控犯有刑事罪行的退伍军人组成的横断面样本。
65名(21.3%)涉及司法程序的退伍军人报告有过终身使用SCRAs的经历。2008年后入伍的退伍军人中有15.0%报告在服役期间使用过。只有8名(12.3%)报告使用SCRAs是为了替代大麻。更常被报告的动机是无聊(36.9%)、尝试(27.7%)以及SCRAs使用的社交方面(32.3%)。逻辑回归模型表明,在军队服役期间使用大麻(调整后风险比[aPR]=2.06,p<0.05)、致幻剂(aPR=2.50,p<0.01)和SCRAs(aPR=2.49,p<0.05)是退伍后使用SCRAs的风险因素,而退伍时年龄较大是一个保护因素(aPR=0.87,p<0.01)。结论:军队中的药物检测项目似乎并未产生将个人导向更具风险药物的意外后果;然而,SCRAs在军队中似乎一直是一个未得到充分重视的问题。此外,使用范围超出了军队,许多人仅在退伍后才开始使用,这表明使用SCRAs可能会危及退伍军人退伍后的健康。